Reply to Comment on: Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3

Am J Ophthalmol. 2020 Apr:212:187-188. doi: 10.1016/j.ajo.2019.11.022. Epub 2020 Jan 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Central Serous Chorioretinopathy*
  • Fluorescein Angiography
  • Humans
  • Lasers
  • Photochemotherapy*
  • Photosensitizing Agents

Substances

  • Photosensitizing Agents